aap Implantate AG Cash Flow-to-Debt Ratio
aap Implantate AG cash flow-to-debt ratio. aap Implantate AG (AAQ1) has a Cash Flow-to-Debt Ratio of -0.07x as of June 2022, meaning its operating cash flow of €-659.50K could theoretically repay 0% of its total liabilities (€9.01 Million) in one year. See how financially flexible is aap Implantate AG to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of aap Implantate AG (2016–2024)
Cash flow-to-debt ratio of aap Implantate AG from 2016 to 2024. Historical debt coverage capacity for aap Implantate AG across 9 annual periods. Also explore aap Implantate AG annual equity growth to track the company's year-over-year net asset growth rate.
aap Implantate AG Cash Flow-to-Debt Ratio by Year (2016–2024)
aap Implantate AG cash flow-to-debt ratio by year from 2016 to 2024. Year-by-year debt coverage analysis for aap Implantate AG. For the full cash flow conversion analysis, see AAQ1 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.21x | €-1.12 Million | €5.38 Million | ▲ +34.1% |
| 2023 | -0.32x | €-2.92 Million | €9.18 Million | ▼ -24.1% |
| 2022 | -0.26x | €-1.89 Million | €7.40 Million | ▼ -5.4% |
| 2021 | -0.24x | €-2.47 Million | €10.18 Million | ▲ +37.8% |
| 2020 | -0.39x | €-3.67 Million | €9.41 Million | ▲ +49.8% |
| 2019 | -0.78x | €-5.77 Million | €7.42 Million | ▲ +4.1% |
| 2018 | -0.81x | €-5.92 Million | €7.30 Million | ▼ -18.1% |
| 2017 | -0.69x | €-5.43 Million | €7.91 Million | ▲ +13.5% |
| 2016 | -0.79x | €-7.20 Million | €9.07 Million | — |